Cell surface-localized matrix 
	metalloproteinase-9 proteolytically
	activates TGF-beta and promotes tumor invasion and angiogenesis.
Yu Q, Stamenkovic I
Molecular Pathology Unit, 
	Massachusetts General Hospital, and Department of Pathology, Harvard Medical 
	School,
	Boston, Massachusetts 02129 USA. 
We have uncovered a novel functional relationship between the hyaluronan receptor CD44, the matrix metalloproteinase-9 (MMP-9) and the multifunctional cytokine TGF-beta in the control of tumor-associated tissue remodeling. CD44 provides a cell surface docking receptor for proteolytically active MMP-9 and we show here that localization of MMP-9 to cell surface is required for its ability to promote tumor invasion and angiogenesis. Our observations also indicate that MMP-9, as well as MMP-2, proteolytically cleaves latent TGF-beta, providing a novel and potentially important mechanism for TGF-beta activation. In addition, we show that MMP-9 localization to the surface of normal keratinocytes is CD44 dependent and can activate latent TGF-beta. These observations suggest that coordinated CD44, MMP-9, and TGF-beta function may provide a physiological mechanism of tissue remodeling that can be adopted by malignant cells to promote tumor growth and invasion.
MeSH Terms:
 Animal 
	Antigens, CD44/physiology 
	Cell Membrane/enzymology 
	Culture Media, Conditioned/pharmacology 
	Endothelium, Vascular/pathology 
	Endothelium, Vascular/enzymology 
	Gelatinase B/metabolism* 
	Hydrolysis 
	Keratinocytes/metabolism 
	Keratinocytes/enzymology 
	Male 
	Mammary Neoplasms, Experimental/pathology 
	Mammary Neoplasms, Experimental/enzymology 
	Mammary Neoplasms, Experimental/blood supply* 
	Mice 
	Mice, Inbred A 
	Mice, Mutant Strains 
	Neoplasm Invasiveness 
	Neovascularization, Pathologic/pathology 
	Neovascularization, Pathologic/metabolism 
	Neovascularization, Pathologic/enzymology* 
	Peptide Hydrolases/metabolism* 
	Protein Isoforms/metabolism 
	Support, U.S. Gov't, P.H.S. 
	Transforming Growth Factor beta/metabolism* 
	Tumor Cells, Cultured 
Substances:
 Transforming Growth Factor 
	beta 
	Protein Isoforms 
	Culture Media, Conditioned 
	Antigens, CD44 
	Gelatinase B 
	Peptide Hydrolases 
Grant support:
 CA09216/CA/NCI 
	GM48614/GM/NIGMS 
	CA55375/CA/NCI 
PMID: 10652271, UI: 20119177